TruAlt Bioenergy Stock Price Today (NSE: TRUALT)
Fundamental Score
TruAlt Bioenergy Share Price Live NSE/BSE & Institutional Fundamental Analysis
TruAlt Bioenergy share price today is ₹419.40, up +0.00% on NSE/BSE as of 1 December 2025. TruAlt Bioenergy (TRUALT) is a Small-cap company in the Other Agricultural Products sector with a market capitalisation of ₹3.60K (Cr). The 52-week high for TRUALT share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 28.29x, TRUALT is currently trading above its industry average P/E of 21.07x. The company has a Return on Equity (ROE) of 28.37% and a debt-to-equity ratio of 1.10.
TruAlt Bioenergy Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
TruAlt Bioenergy Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
TruAlt Bioenergy Share Price: A Financial Analysis
One interesting trend in the Other Agricultural Products sector is the increasing investor focus on companies demonstrating sustainable and vertically integrated supply chains. This analysis examines the financial stability of TruAlt Bioenergy, focusing on its current valuation and profitability metrics. The current TruAlt Bioenergy share price stands at ₹419.4, with a Price-to-Earnings (PE) ratio of 28.29 and a Return on Capital Employed (ROCE) of 14.18%. This initial overview suggests a company valued with expectations of future growth, but a deeper dive is needed to assess the sustainability of this valuation.
The PE ratio of 28.29 suggests that investors are paying a premium for each rupee of earnings. This indicates a strong belief in the company's future prospects, potential for higher growth, or a perception of lower risk compared to its peers. However, it also necessitates that TruAlt Bioenergy consistently delivers strong earnings growth to justify this valuation. A comparison with sector peers is crucial.
Comparing TruAlt Bioenergy with peers like
Kaveri Seed Company Limited, it's important to consider factors beyond just financial ratios. Assessing management quality, strategic vision, and execution capabilities becomes paramount. While quantitative data provides a snapshot of current performance, qualitative aspects play a crucial role in predicting long-term success. For instance, if Kaveri Seed Company Limited is perceived to have a more experienced or effective management team, it could justify a different valuation, even with similar financial metrics.The 14.18% ROCE is a significant indicator of how efficiently TruAlt Bioenergy is deploying its capital to generate profits. A higher ROCE generally translates to a stronger competitive advantage or "moat". In this case, the 14.18% ROCE suggests a reasonably good level of capital efficiency. However, the sustainability of this ROCE is key. Factors influencing this include the company's ability to maintain pricing power, control costs, and reinvest in profitable growth opportunities. Sustained high ROCE contributes towards building a stronger brand, securing strategic partnerships and ultimately a wider competitive moat.
This financial analysis of TruAlt Bioenergy is based on publicly available information and is part of an 80-parameter fundamental audit verified by Sweta Mishra. It is purely observational and does not constitute investment advice.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
TruAlt Bioenergy Fundamental Analysis & Valuation Benchmarking
Educational evaluation of TRUALT across key market metrics for learning purposes.
Positive Indicators
3 factors identified
Strong Return on Equity (28.37%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Balanced Promoter Holding (70.55%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
6 factors identified
Profit Decline Concern (-103.32%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-70.41%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Elevated Debt Levels (D/E: 1.10)
Observation: High leverage increases financial risk and interest burden.
Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.
Weak Interest Coverage (2.11x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Limited Institutional Interest (FII+DII: 9.10%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
TruAlt Bioenergy Financial Statements
Comprehensive financial data for TruAlt Bioenergy including income statement, balance sheet and cash flow
About TRUALT (TruAlt Bioenergy)
TruAlt Bioenergy (TRUALT) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Other Agricultural Products sector with a current market capitalisation of ₹3.60K (Cr). TruAlt Bioenergy has delivered a Return on Equity (ROE) of 28.37% and a ROCE of 14.18%. The debt-to-equity ratio stands at 1.10, reflecting the company's capital structure. Investors tracking TRUALT share price can monitor key metrics including P/E ratio, promoter holding of 70.55%, and quarterly earnings growth.
Company Details
TRUALT Share Price: Frequently Asked Questions
What is the current share price of TruAlt Bioenergy (TRUALT)?
As of 01 Dec 2025, 04:21 pm IST, TruAlt Bioenergy share price is ₹419.40. The TRUALT stock has a market capitalisation of ₹3.60K (Cr) on NSE/BSE.
Is TRUALT share price Overvalued or Undervalued?
TRUALT share price is currently trading at a P/E ratio of 28.29x, compared to the industry average of 21.07x. Based on this relative valuation, the TruAlt Bioenergy stock appears to be Overvalued against its sector peers.
What is the 52-week high and low of TRUALT share price?
The 52-week high of TRUALT share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the TruAlt Bioenergy share price?
Key factors influencing TRUALT share price include quarterly earnings growth (Sales Growth: -70.41%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is TruAlt Bioenergy a good stock for long-term investment?
TruAlt Bioenergy shows a 5-year Profit Growth of N/A% and an ROE of 28.37%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 1.10 before investing in TRUALT shares.
How does TruAlt Bioenergy compare with its industry peers?
TruAlt Bioenergy competes with major peers in the Other Agricultural Products. Investors should compare TRUALT share price P/E of 28.29x and ROE of 28.37% against the industry averages to determine competitive standing.
What is the P/E ratio of TRUALT and what does it mean?
TRUALT share price has a P/E ratio of 28.29x compared to the industry average of 21.07x. Investors pay ₹28 for every ₹1 of annual earnings.
How is TRUALT performing according to Bull Run's analysis?
TRUALT has a Bull Run fundamental score of N/A/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does TRUALT belong to?
TRUALT operates in the Other Agricultural Products industry. This classification helps understand the competitive landscape and sector-specific trends affecting TruAlt Bioenergy share price.
What is Return on Equity (ROE) and why is it important for TRUALT?
TRUALT has an ROE of 28.37%, which indicates excellent management efficiency. ROE measures how efficiently TruAlt Bioenergy generates profits from shareholders capital.
How is TRUALT debt-to-equity ratio and what does it indicate?
TRUALT has a debt-to-equity ratio of 1.10, which indicates high leverage that increases financial risk.
What is TRUALT dividend yield and is it a good dividend stock?
TRUALT offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in TruAlt Bioenergy shares.
How has TRUALT share price grown over the past 5 years?
TRUALT has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in TRUALT and why does it matter?
Promoters hold 70.55% of TRUALT shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in TruAlt Bioenergy.
What is TRUALT market capitalisation category?
TRUALT has a market capitalisation of ₹3603 crores, placing it in the Small-cap category.
How volatile is TRUALT stock?
TRUALT has a beta of N/A. A beta > 1 suggests the TruAlt Bioenergy stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is TRUALT operating profit margin trend?
TRUALT has a 5-year average Operating Profit Margin (OPM) of N/A%, indicating the company's operational efficiency.
How is TRUALT quarterly performance?
Recent quarterly performance shows TruAlt Bioenergy YoY Sales Growth of -70.41% and YoY Profit Growth of -103.32%.
What is the institutional holding pattern in TRUALT?
TRUALT has FII holding of 1.30% and DII holding of 7.80%. Significant institutional holding often suggests professional confidence in the TruAlt Bioenergy stock.